Benzimidazole modulators of VR1

US7951829B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Mark R. Player · Phoenixville, US
• Scott L. Dax · Landenberg, US
• William H. Parsons · Montgomery, US
• Michael Brandt · Iffeldorf, DE
• Raul Calvo · Royersford, US
• Sharmila Patel · Jamison, US
• Jian Liu · Xi'an, CN
• Wing S. Cheung · Plainsboro, US
• Michele C. Jetter · Norristown, US
• Yu-Kai Lee · Exton, US
• Mark A. Youngman · Warminster, US
• Wenxi Pan · Radnor, US
• Kenneth M. Wells · Somerville, US
• Derek Beauchamp · Dexter, US

Key dates

• Filing date: Apr 13, 2007
• Grant date: May 31, 2011
• Expiry date: Dec 2, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention is directed to compounds of Formula (I):to pharmaceutical compositions containing such compounds and to methods of treatment using them.